Teleflex (Limerick, Pennsylvania) said it has acquired Semprus BioSciences (Cambridge, Massachusetts), a biomedical company and spinout from Massachusetts Institute of Technology (MIT; Cambridge), for an up-front payment of $30 million. The acquisition includes the core Semprus Sustain technology.

While most people think of pacemakers as the small electrical devices implanted in a person's chest or abdomen to help control abnormal heart rhythms, Medtronic (Minneapolis) is offering a similar device one that is implanted in a patient's lower backside to help control incontinence.

Edwards Lifesciences (Irvine, California) said it has received a conditional investigational device exemption (IDE) from the FDA to initiate a clinical trial to study its GLX next-generation tissue treatment platform applied to a surgical bovine pericardial heart valve.